Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Dichloromethane | HCID 6344 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | HCID 10249252 | HCID 10249252 | — |
| Reactant | (S)-3-Benzylmorpholine | HCID 10487535 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 5276323 | HCID 5276323 | 58.4% |
Reaction Steps
N-(4-Chlorobenzyl)-2-(chloromethyl)-7-methyl-4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamide (Preparation 1, 100 mg) and diisopropylethylamine (0.13 mL) is added to a mixture of (S)-3-(phenylmethyl)morpholine (93 mg, prepared as described by Shawe, T. T. Syn. Comm. 1997,27,1777-1782) in DMF (5 mL). The mixture is heated at 90° C. for 3 hours. After cooling to room temperature, the solution is poured into CH2Cl2 (125 mL) and washed with water (2×100 mL). The organic layer is dried (Na2SO4) and the solution filtered. Evaporation of the solvent gives a residue which is purified by column chromatography (methanol/CH2Cl2, 0-6%) to obtain 80 mg of the title compound. Physical characteristics. 1H NMR (400 MHz, DMSO-d6) δ 10.61, 8.71, 7.41-7.20, 4.54, 4.20, 3.96, 3.91, 3.59, 3.41, 3.20, 2.89, 2.82-2.66, 2.40; MS (ESI+) m/z 522 (M+H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06831081B2 |
|---|
| Source dataset | uspto-grants-2004_12 |
|---|
| ORD ID | ord-2cf79acff0724bbea3b299008c63d975 |
|---|
| Source note | uspto-grants-2004_12 |
|---|